T1	Haplotype	0 20	In CYP3A5 * 1 allele
T2	Phenotype	32 49	CYP3A5 expressers
T3	Pharmacokinetic_phenotype	80 93	clearance was
T4	Phenotype	332 356	non-expressers ; however
T5	Limited_variation	378 391	variation did
T6	Pharmacokinetic_phenotype	417 441	chronopharmacokinetics .
R1	treats	Arg1:T1	Arg2:T2
R2	decreases	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	influences	Arg1:T1	Arg2:T6
R6	isEquivalentTo	Arg1:T2	Arg2:T1
R7	decreases	Arg1:T2	Arg2:T3
R8	isAssociatedWith	Arg1:T2	Arg2:T4
R9	isAssociatedWith	Arg1:T2	Arg2:T5
R10	influences	Arg1:T2	Arg2:T6
R11	isAssociatedWith	Arg1:T3	Arg2:T1
R12	isAssociatedWith	Arg1:T3	Arg2:T2
R13	isAssociatedWith	Arg1:T3	Arg2:T4
R14	isAssociatedWith	Arg1:T3	Arg2:T5
R15	isAssociatedWith	Arg1:T3	Arg2:T6
R16	influences	Arg1:T4	Arg2:T1
R17	influences	Arg1:T4	Arg2:T2
R18	decreases	Arg1:T4	Arg2:T3
R19	influences	Arg1:T4	Arg2:T5
R20	influences	Arg1:T4	Arg2:T6
R21	influences	Arg1:T5	Arg2:T1
R22	influences	Arg1:T5	Arg2:T2
R23	influences	Arg1:T5	Arg2:T3
R24	influences	Arg1:T5	Arg2:T4
R25	influences	Arg1:T5	Arg2:T6
R26	isAssociatedWith	Arg1:T6	Arg2:T1
R27	isAssociatedWith	Arg1:T6	Arg2:T2
R28	decreases	Arg1:T6	Arg2:T3
R29	isAssociatedWith	Arg1:T6	Arg2:T4
R30	isAssociatedWith	Arg1:T6	Arg2:T5
